Sign in

You're signed outSign in or to get full access.

LG

LanzaTech Global, Inc. (LNZA)·Q2 2025 Earnings Summary

Executive Summary

  • Q2 revenue modestly beat thin Street consensus at $9.084M vs $9.0M, but the loss profile worsened versus expectations as Adjusted EBITDA loss of $(29.7)M trailed the $(26.5)M consensus; EPS was in line at $(0.15) *. Revenue decline YoY reflected lower licensing and engineering/services, partially offset by a sharp CarbonSmart ramp .
  • Management executed liquidity and cost actions: $40M preferred equity closed in May (cash/short-term investments rose to $39.6M at 6/30) and workforce reductions/leadership changes to pivot from R&D to commercial execution .
  • Strategic momentum in SAF: £6.4M UK grant (DRAGON 1&2) to accelerate SAF projects leveraging LanzaTech ethanol-to-jet platform; management emphasized capital-light growth via licensing/partnerships .
  • Governance/listing: 1-for-100 reverse stock split approved/implemented as part of Nasdaq compliance plan, effective Aug 18-19, 2025 .
  • No formal financial guidance provided; narrative focuses on cost efficiency, SAF scaling, and partnership-led commercialization .

What Went Well and What Went Wrong

  • What Went Well

    • CarbonSmart revenue scaled materially to $3.8M from $0.9M YoY on higher product volumes, partially cushioning declines in other lines .
    • Liquidity bolstered: cash, restricted cash and investments rose to $39.6M at quarter-end, aided by a $40M preferred equity raise in May .
    • Strategic tailwinds in SAF: receipt of a £6.4M UK Advanced Fuels Fund grant for DRAGON 1&2 SAF projects; CEO: “Our platform’s ability to convert carbon waste into SAF will position us to play a critical role in aviation decarbonization.”
  • What Went Wrong

    • Top line down sharply YoY: revenue fell to $9.084M from $17.375M as last year benefited from LanzaJet sublicensing and higher engineering/services; licensing was $1.1M vs $8.5M YoY .
    • Profitability deterioration: Adjusted EBITDA loss widened to $(29.7)M vs $(17.8)M YoY on lower revenue and mix shift to lower-margin CarbonSmart; short-term restructuring costs also weighed .
    • Continued losses and going concern warnings in risk disclosures; Nasdaq compliance actions required a 1-for-100 reverse split (executed mid-August) .

Financial Results

Note: Q2 2025 press release headline revenue cites ~$9.1M; the detailed statement of operations shows $9.084M. We present the detailed figure for consistency .

MetricQ2 2024Q1 2025Q2 2025YoY %QoQ %Consensus (Q2 2025)Vs Cons
Revenue ($USD Millions)$17.375 $9.483 $9.084 -47.7%-4.2%$9.000*+$0.084
Net Loss ($USD Millions)$(27.799) $(19.229) $(32.499) +16.9% (worse)-69.0% (worse)
Adjusted EBITDA ($USD Millions)$(17.752) $(30.507) $(29.696) -67.3% (worse)+2.7%$(26.5)*-$3.196
EPS (Basic & Diluted, $)$(0.14) $(0.10) $(0.15) $(0.01)$(0.05)$(0.15)*In line
  • Estimates sourced from S&P Global; coverage is thin (1 estimate for EPS and revenue) [GetEstimates]. Values marked with * are from S&P Global.

Revenue breakdown (management categories):

Revenue Category ($USD Millions)Q2 2024Q2 2025
Licensing$8.5 $1.1
Engineering & Other Services$5.1 $1.9
JDA & Contract Research$2.8 $2.3
CarbonSmart$0.9 $3.8

Select KPIs and operating items:

KPIQ2 2024Q1 2025Q2 2025
Cost of Revenue ($M)$5.5 $7.5 $6.2
Operating Expenses ($M)$34.7 $33.0 $35.1
Weighted Avg Shares (Basic & Diluted)197,746,569 196,514,267 218,121,734
Cash, Restricted Cash & Investments ($M, end)$23.4 $39.6
Net Cash Used in Operating Activities (YTD) ($M)$(21.101) $(42.815)

Drivers:

  • YoY revenue decline primarily due to reduced licensing (prior-year LanzaJet sublicensing uplift) and lower engineering/services; partially offset by CarbonSmart growth .
  • Higher cost of revenue YoY reflects mix shift toward CarbonSmart (lower margin vs biorefining/JDA) .
  • Adjusted EBITDA deterioration reflects lower revenue, higher cost of sales, and restructuring-related costs; some non-cash fair value gains offset net loss dynamics .

Guidance Changes

No formal quantitative guidance was provided for revenue, EBITDA, margins, or other P&L line items.

MetricPeriodPrevious GuidanceCurrent GuidanceChange
RevenueFY/QuarterNoneNone disclosedMaintained (no guidance)
Adjusted EBITDAFY/QuarterNoneNone disclosedMaintained (no guidance)
Liquidity/Capital ActionsN/A$40M preferred equity (May 2025)New (liquidity bolstered)
Listing ComplianceN/A1-for-100 reverse stock split (effective Aug 18-19, 2025)New (Nasdaq plan)

Earnings Call Themes & Trends

Note: A Q2 2025 earnings call transcript was not available in the document catalog. Themes below reflect Q4 2024 and Q1 2025 earnings materials and Q2 2025 press releases.

TopicPrevious Mentions (Q-2: Q4 2024)Previous Mentions (Q-1: Q1 2025)Current Period (Q2 2025)Trend
SAF commercializationTiming delays on large biorefining projects; SAF-related activity ongoing Pivot to global deployment; CarbonSmart ramp noted £6.4M UK grant for DRAGON 1&2; emphasis on SAF platform and partnerships Improving
Cost structure/operating efficiencyOpEx elevated from project-related expenses Streamlining operations; cost structure focus Workforce reductions; leadership transitions for efficiency Improving (actions ongoing)
Liquidity/going concern2024: liquidity initiatives; going concern noted $40M preferred equity; going concern still highlighted Higher period-end cash from financing; going concern risks still cited in FLS Mixed
Revenue mix and marginsLower licensing/services YoY; CarbonSmart up; 4Q24 margin mix headwinds CarbonSmart up; biorefining/JDA down CarbonSmart up materially; mix pressures persist Stable (same mix issue)
Partnerships/licensingExpect additional LanzaJet shares on sublicensing Capital-light model via licensing highlighted “Capital-light growth” via licensing/partnerships reiterated Stable to positive
Regulatory/grantsDoE Project SECURE phase one in 4Q24 UK Advanced Fuels Fund grant awarded Positive
Listing/NasdaqNon-compliance risk referenced Reverse split executed for compliance plan Positive (process executed)

Management Commentary

  • “We are focused on building a more efficient, scalable business with a path to profitability… shift resources toward commercial execution especially relating to the high-growth market for sustainable aviation fuel.” — Dr. Jennifer Holmgren, CEO .
  • “Prioritizing capital-light growth through licensing and partnerships, supported by strong regulatory and customer momentum.” — Dr. Holmgren .
  • Strategic updates included workforce reductions and executive leadership transitions to align cost structure with long-term objectives .

Q&A Highlights

  • No Q2 2025 earnings call transcript was available in the catalog; therefore, Q&A highlights are not available for this quarter.

Estimates Context

  • Q2 2025 consensus (S&P Global): Revenue $9.0M*, EPS $(0.15), EBITDA $(26.5)M; # of estimates: 1 for EPS and revenue. Actuals: Revenue $9.084M (beat), EPS $(0.15) (in line), Adjusted EBITDA $(29.7)M (miss) .
  • Thin coverage suggests estimates may be volatile/incomplete and subject to larger revisions as visibility on licensing cycles and SAF project timing evolves.
  • Expect estimate revisions: likely modest top-line stability but continued EBITDA pressure until mix shifts or cost savings fully materialize.

Estimates vs Actuals

MetricConsensus (Q2 2025)Actual (Q2 2025)Surprise
Revenue ($USD Millions)$9.000*$9.084 +$0.084
EPS ($)$(0.15)*$(0.15) In line
EBITDA/Adj. EBITDA ($USD Millions)$(26.5)*$(29.696) -$3.196
  • Values marked with * were retrieved from S&P Global.

Key Takeaways for Investors

  • Execution pivot is tangible (workforce/leadership changes) with liquidity improved by $40M preferred equity; however, going concern risk remains flagged in disclosures—monitor additional financing/cost actions .
  • Revenue quality is mixed: CarbonSmart growth is strong, but licensing and engineering/services remain choppy; EBITDA remains pressured by mix and restructuring costs—watch for evidence of higher-margin licensing resumption and cost saves flowing through .
  • SAF optionality improving: UK grant for DRAGON projects and reiterated capital-light partnership approach could unlock scale; catalysts include additional awards/offtakes and LanzaJet sublicensing events .
  • Listing risk mitigation: reverse split completed as part of Nasdaq compliance plan reduces near-term delisting overhang; next steps include sustaining minimum bid and continued balance sheet strengthening .
  • Near-term trading: modest revenue beats may be overshadowed by EBITDA misses; stock likely most sensitive to funding visibility, project milestones, and concrete cost-out progress .
  • Medium-term thesis: if SAF commercialization advances and licensing normalizes, LanzaTech’s capital-light model could expand margins; execution on cost structure and project timing are pivotal .

Citations:

  • Q2 2025 8-K 2.02 press release and exhibits .
  • Q1 2025 8-K 2.02 press release and exhibits .
  • Q4 2024 8-K 2.02 press release and exhibits .
  • Reverse stock split 8-K and press release .

S&P Global disclaimer: Values marked with * are retrieved from S&P Global.